PubMed for id: 26414

Year	Number of Results
1995	1
1996	3
1997	1
1999	4
2000	2
2001	3
2002	3
2003	3
2004	6
2005	8
2006	9
2007	6
2008	4
2009	5
2010	4
2011	12
2012	6
2013	4
2014	5
2015	5
2016	5
2017	5
2018	3
2019	4
2020	3
2021	2
2022	2
2023	1
2024	1

1

Genetic deletion of c-Jun amino-terminal kinase 3 (JNK3) modestly increases disease severity in a mouse model of multiple sclerosis.

Priego M, Noriega L, Kalinin S, Hoffman LM, Feinstein DL, Morfini G. Priego M, et al. J Neuroimmunol. 2023 Sep 15;382:578152. doi: 10.1016/j.jneuroim.2023.578152. Epub 2023 Jul 12. J Neuroimmunol. 2023. PMID: 37454525

2

Time series RNA-seq analysis identifies MAPK10 as a critical gene in diabetes mellitus-induced atrial fibrillation in mice.

Liu F, Deng Y, Zhao Y, Li Z, Gao J, Zhang Y, Yang X, Liu Y, Xia Y. Liu F, et al. J Mol Cell Cardiol. 2022 Jul;168:70-82. doi: 10.1016/j.yjmcc.2022.04.013. Epub 2022 Apr 27. J Mol Cell Cardiol. 2022. PMID: 35489387 Free article.

3

Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding.

Carulla P, Bribián A, Rangel A, Gavín R, Ferrer I, Caelles C, Del Río JA, Llorens F. Carulla P, et al. Mol Biol Cell. 2011 Sep;22(17):3041-54. doi: 10.1091/mbc.E11-04-0321. Epub 2011 Jul 14. Mol Biol Cell. 2011. PMID: 21757544 Free PMC article.

4

Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice.

Quigley HA, Cone FE, Gelman SE, Yang Z, Son JL, Oglesby EN, Pease ME, Zack DJ. Quigley HA, et al. Exp Eye Res. 2011 Apr;92(4):299-305. doi: 10.1016/j.exer.2011.01.006. Epub 2011 Jan 25. Exp Eye Res. 2011. PMID: 21272576 Free PMC article.

5

JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction.

Yu J, Novgorodov SA, Chudakova D, Zhu H, Bielawska A, Bielawski J, Obeid LM, Kindy MS, Gudz TI. Yu J, et al. J Biol Chem. 2007 Aug 31;282(35):25940-9. doi: 10.1074/jbc.M701812200. Epub 2007 Jul 3. J Biol Chem. 2007. PMID: 17609208 Free article.

6

Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice.

Harder JM, Williams PA, Soto I, Foxworth NE, Fernandes KA, Freeburg NF, Libby RT, John SWM. Harder JM, et al. Cell Death Dis. 2018 Jun 13;9(6):705. doi: 10.1038/s41419-018-0705-8. Cell Death Dis. 2018. PMID: 29899326 Free PMC article.

7

Neuroprotective Effects of the Absence of JNK1 or JNK3 Isoforms on Kainic Acid-Induced Temporal Lobe Epilepsy-Like Symptoms.

de Lemos L, Junyent F, Camins A, Castro-Torres RD, Folch J, Olloquequi J, Beas-Zarate C, Verdaguer E, Auladell C. de Lemos L, et al. Mol Neurobiol. 2018 May;55(5):4437-4452. doi: 10.1007/s12035-017-0669-1. Epub 2017 Jun 29. Mol Neurobiol. 2018. PMID: 28664455

8

Genetic inhibition of JNK3 ameliorates spinal muscular atrophy.

Genabai NK, Ahmad S, Zhang Z, Jiang X, Gabaldon CA, Gangwani L. Genabai NK, et al. Hum Mol Genet. 2015 Dec 15;24(24):6986-7004. doi: 10.1093/hmg/ddv401. Epub 2015 Sep 30. Hum Mol Genet. 2015. PMID: 26423457 Free PMC article.

9

Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3.

Chintala SK, Putris N, Geno M. Chintala SK, et al. Invest Ophthalmol Vis Sci. 2015 Jan 6;56(1):505-14. doi: 10.1167/iovs.14-15539. Invest Ophthalmol Vis Sci. 2015. PMID: 25564448 Free PMC article.

10

JNK3 perpetuates metabolic stress induced by Aβ peptides.

Yoon SO, Park DJ, Ryu JC, Ozer HG, Tep C, Shin YJ, Lim TH, Pastorino L, Kunwar AJ, Walton JC, Nagahara AH, Lu KP, Nelson RJ, Tuszynski MH, Huang K. Yoon SO, et al. Neuron. 2012 Sep 6;75(5):824-37. doi: 10.1016/j.neuron.2012.06.024. Neuron. 2012. PMID: 22958823 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year